Identification & Testing of Novel Cancer-Restricted Targets & Their TCRS to Develop Safe & Effective T-Cell Treatment
Time: 5:30 pm
day: Day 1 – Track A – Evening
Details:
To fully exploit the therapeutic potential of TCR-T cells, we use our platform to:
- Limit toxicity attributed to recognition of identical or highly similar targets outside cancers
- Deliver shared intracellular targets that are cancer-selective to treat large cohorts of patients
- Counteract the immune-suppressive nature of tumour microenvironments
